- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06515379
Emergency Department Management of Patients With Renal Infarction
Study Overview
Status
Detailed Description
It is planned to include 80 patients who presented to the hospital emergency department and were diagnosed with renal infarction between January 1, 2014, and June 1, 2023, in the study.
he data of patients diagnosed with renal infarction will be retrospectively collected from the hospital database and recorded in a data collection form. This includes information such as CBC (complete blood count), neutrophils, lymphocytes, platelets, lactate, anion gap, pH, bicarbonate, creatinine, urea, AST, ALT, fibrinogen, D-dimer, LDH, CRP, CT scan, and CT angiography results. Patients' demographic characteristics, physical examination findings, imaging, and laboratory results will be evaluated using patient records and the hospital registry system.
Our aim is to identify early morbidity and mortality indicators in cases of renal infarction where diagnosis is often delayed or missed, contributing to the survival of patients. We believe that the findings from our statistical analysis can guide routine practice, especially in the management of patients presenting to the emergency department with complaints of abdominal and/or flank pain
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Altindag
-
Ankara, Altindag, Turkey, 06110
- Diskapi Teaching and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion criteria:
Adult patients aged 18 years and older Cases diagnosed with renal infarction presenting to the Emergency Department of Dışkapı Yıldırım Beyazıt Training and Research Hospital
Exclusion criteria:
Patients without imaging methods Patients with incomplete laboratory and file follow-ups Patients previously diagnosed with renal infarction and currently under treatment Patients diagnosed with other clinical conditions such as pyelonephritis, lower urinary tract infections, nephrolithiasis
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Renal Infarction
Patients diagnosed with renal infarction using data obtained from the hospital system have been reviewed and evaluated.
Laboratory, clinical and imaging data ahve been registered and statistical analyses have been conducted
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Renal Infarction
Time Frame: 9 years
|
patients diagnosed with renal infarction
|
9 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: gulsen akcay, ass. prof., ass. prof. of organization
Publications and helpful links
General Publications
- Delezire A, Terrasse M, Bouet J, Laot M, Brun V, Oger E, Vigneau C. Acute renal infarction: long-term renal outcome and prognostic factors. J Nephrol. 2021 Oct;34(5):1501-1509. doi: 10.1007/s40620-020-00953-4. Epub 2021 Mar 25.
- Francisco D, Pimenta G, Martins AC, Laranjinha I, Estibeiro H, Gil C, Goncalves M, Gaspar MA. Recovering from a renal vascular catastrophe: Case report. Clin Nephrol Case Stud. 2023 Mar 5;11:44-49. doi: 10.5414/CNCS110984. eCollection 2023.
- Woo S, Lee CA, Lee JW, Moon J, Cho YS, Nah S, Han S. Predictors for Distinguishing Renal Infarction From Urolithiasis in the Emergency Department: A Randomly Matched Retrospective Case-Control Study. J Emerg Med. 2023 Jan;64(1):31-39. doi: 10.1016/j.jemermed.2022.10.009. Epub 2023 Jan 12.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RENAL INFARCTION
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Infarct
-
All India Institute of Medical Sciences, New DelhiIndian Council of Medical ResearchUnknownHoming of Stem Cells in the Infarct Area.India
-
University Hospital, MontpellierCompletedAcute Myocardial InfarctFrance
-
YiLinRecruitingLarge Infarct Core | Post-stroke LymphocytopeniaChina
-
Thrombologic ApSRigshospitalet, Denmark; Lene HolmvangCompletedMyocardial InfarctDenmark
-
Helse Stavanger HFHelse Vest; Amersham Buchler, GmbH & Co KGCompletedMyocardial Infarct | Heart FailureNorway
-
Insel Gruppe AG, University Hospital BernRecruitingSilent Cerebral Infarct | Silent Stroke | Silent Brain Infarction | Covert Brain Infarct | Covert Brain Infarction | LacuneSwitzerland, France
-
Dexa Medica GroupTerminatedAcute Ischemic Stroke | Partial Anterior Circulation Infarct | Lacunar Anterior Circulation InfarctIndonesia
-
The First Affiliated Hospital of Hainan Medical...RecruitingBasilar Artery Occlusion | Large Ischemic Core | Endovascular Treatments | Large Core InfarctChina
-
Feng GaoEnrolling by invitationAcute Basilar Artery Occlusion | Posterior Circulation Large InfarctChina
-
Imperial College LondonSt Mary's Hospital, LondonSuspendedStroke | Silent Cerebral InfarctUnited Kingdom